ES2744979T8 - Poblaciones de células renales y usos de las mismas - Google Patents

Poblaciones de células renales y usos de las mismas

Info

Publication number
ES2744979T8
ES2744979T8 ES13786132T ES13786132T ES2744979T8 ES 2744979 T8 ES2744979 T8 ES 2744979T8 ES 13786132 T ES13786132 T ES 13786132T ES 13786132 T ES13786132 T ES 13786132T ES 2744979 T8 ES2744979 T8 ES 2744979T8
Authority
ES
Spain
Prior art keywords
cell populations
renal cell
renal
populations
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES13786132T
Other languages
English (en)
Other versions
ES2744979T3 (es
Inventor
Joydeep Basu
Kelly Guthrie
Dominic Justewicz
Teresa Burnette
Andrew Bruce
Russell W Kelley
John W Ludlow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inregen Inc
Original Assignee
Inregen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inregen Inc filed Critical Inregen Inc
Application granted granted Critical
Publication of ES2744979T3 publication Critical patent/ES2744979T3/es
Publication of ES2744979T8 publication Critical patent/ES2744979T8/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0684—Cells of the urinary tract or kidneys
    • C12N5/0686—Kidney cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/02—Atmosphere, e.g. low oxygen conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/58—Adhesion molecules, e.g. ICAM, VCAM, CD18 (ligand), CD11 (ligand), CD49 (ligand)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/599—Cell markers; Cell surface determinants with CD designations not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C12N2509/10—Mechanical dissociation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4742—Keratin; Cytokeratin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91045—Acyltransferases (2.3)
    • G01N2333/91074—Aminoacyltransferases (general) (2.3.2)
    • G01N2333/9108—Aminoacyltransferases (general) (2.3.2) with definite EC number (2.3.2.-)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ES13786132T 2012-10-24 2013-10-24 Poblaciones de células renales y usos de las mismas Active ES2744979T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261718150P 2012-10-24 2012-10-24
US201361876616P 2013-09-11 2013-09-11
PCT/US2013/066707 WO2014066699A1 (en) 2012-10-24 2013-10-24 Renal cell populations and uses thereof

Publications (2)

Publication Number Publication Date
ES2744979T3 ES2744979T3 (es) 2020-02-27
ES2744979T8 true ES2744979T8 (es) 2020-04-28

Family

ID=49517782

Family Applications (2)

Application Number Title Priority Date Filing Date
ES13786132T Active ES2744979T3 (es) 2012-10-24 2013-10-24 Poblaciones de células renales y usos de las mismas
ES19168775T Active ES2876177T3 (es) 2012-10-24 2013-10-24 Poblaciones de células renales y usos de las mismas

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES19168775T Active ES2876177T3 (es) 2012-10-24 2013-10-24 Poblaciones de células renales y usos de las mismas

Country Status (18)

Country Link
US (4) US20150246073A1 (es)
EP (3) EP3901251A1 (es)
JP (2) JP6509119B2 (es)
KR (4) KR102160725B1 (es)
CN (3) CN110184232B (es)
AU (3) AU2013334276B2 (es)
BR (2) BR122020018576B1 (es)
CA (1) CA2889270A1 (es)
DK (2) DK2912165T3 (es)
ES (2) ES2744979T3 (es)
HK (1) HK1215448A1 (es)
HU (2) HUE046176T2 (es)
NZ (2) NZ741724A (es)
PL (2) PL2912165T3 (es)
PT (1) PT2912165T (es)
RU (1) RU2702721C2 (es)
SI (1) SI2912165T1 (es)
WO (1) WO2014066699A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014066699A1 (en) 2012-10-24 2014-05-01 Tengion, Inc. Renal cell populations and uses thereof
US11123372B2 (en) * 2016-07-29 2021-09-21 Prokidney Bioactive renal cells for the treatment of chronic kidney disease
CN109890397A (zh) * 2016-07-29 2019-06-14 迪帕克.简 用于治疗慢性肾病的生物活性肾细胞
JP2020512406A (ja) * 2017-03-31 2020-04-23 ジェイン，ディーパク 注射用の細胞および足場組成物
CN111182921A (zh) * 2017-06-21 2020-05-19 蒂莫西.A.伯特伦 用于治疗肾疾病的免疫豁免的生物活性肾细胞
JP7061766B2 (ja) * 2017-09-20 2022-05-02 学校法人同志社 Ｄｊ－１タンパク質産生促進用組成物
CN109266616A (zh) * 2018-08-21 2019-01-25 山西省人民医院 一种稳定表达aqp2蛋白的人源化小鼠足细胞模型及其构建方法和应用
KR20210098431A (ko) * 2018-08-31 2021-08-10 프로키드니 세포-유래 소포를 포함하는 조성물 및 그의 용도
EP3962500A4 (en) * 2019-05-02 2023-06-07 Timothy A. Bertram TREATMENT OF KIDNEY DISEASE IN SUBJECTS WITH KIDNEY AND/OR URINARY TRACT ABNORMALITIES
WO2021152578A1 (en) * 2020-01-28 2021-08-05 Kidneycure Ltd Process for kidney cell manufacture and treatment
CN116240161B (zh) * 2023-02-27 2024-05-10 四川大学华西医院 具有肾脏损伤修复作用的细胞外囊泡制备方法及应用

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018653A (en) 1971-10-29 1977-04-19 U.S. Packaging Corporation Instrument for the detection of Neisseria gonorrhoeae without culture
US4016043A (en) 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4318980A (en) 1978-04-10 1982-03-09 Miles Laboratories, Inc. Heterogenous specific binding assay employing a cycling reactant as label
US4424279A (en) 1982-08-12 1984-01-03 Quidel Rapid plunger immunoassay method and apparatus
US4737456A (en) 1985-05-09 1988-04-12 Syntex (U.S.A.) Inc. Reducing interference in ligand-receptor binding assays
CA2046830C (en) 1990-07-19 1999-12-14 Patrick P. Deluca Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
US6283761B1 (en) 1992-09-08 2001-09-04 Raymond Anthony Joao Apparatus and method for processing and/or for providing healthcare information and/or healthcare-related information
CA2214889C (en) 1995-03-10 2005-05-24 Hans Koll Polypeptide-containing pharmaceutical forms of administration in the form of microparticles and a process for the production thereof
US6224893B1 (en) 1997-04-11 2001-05-01 Massachusetts Institute Of Technology Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
JP4057781B2 (ja) 1997-10-31 2008-03-05 チルドレンズ メディカル センター コーポレーション 膀胱再構成
CA2325983C (en) 1998-04-20 2009-02-17 Genzyme Corporation Drug delivery of proteins from polymeric blends
DE19933582A1 (de) 1999-07-17 2001-01-18 Gerhard Rosenberger Vorrichtung zum Aufnehmen von Werkstücken und/oder Werkzeugen
US6991652B2 (en) 2000-06-13 2006-01-31 Burg Karen J L Tissue engineering composite
US7197470B1 (en) 2000-10-11 2007-03-27 Buzzmetrics, Ltd. System and method for collection analysis of electronic discussion methods
WO2002082076A2 (en) 2001-04-03 2002-10-17 Merck Patent Gmbh Renal cell carcinoma tumor markers
AU2003207459A1 (en) * 2002-01-03 2003-07-24 The Scripps Research Institute Cancer-associated epitope
EP1491187A4 (en) 2002-03-22 2008-04-16 Kissei Pharmaceutical PREVENTIVE OR THERAPEUTIC AGENT FOR RENAL DISEASES
GB0215509D0 (en) * 2002-07-04 2002-08-14 Novartis Ag Marker genes
US20040139072A1 (en) 2003-01-13 2004-07-15 Broder Andrei Z. System and method for locating similar records in a database
US20050241012A1 (en) * 2003-10-17 2005-10-27 Nigam Sanjay K Multigene profiling in the kidney to tailor drug therapy
US20050108384A1 (en) 2003-10-23 2005-05-19 Lambert John R. Analysis of message sequences
US7788087B2 (en) 2005-03-01 2010-08-31 Microsoft Corporation System for processing sentiment-bearing text
US20080161231A1 (en) * 2005-03-18 2008-07-03 Kintan Pty. Ltd. Methods and compositions for promoting organ development
US20090304639A1 (en) * 2005-04-28 2009-12-10 Takashi Yokoo Method for preparing an organ for transplantation
JP5416415B2 (ja) 2006-02-10 2014-02-12 テンジオン， インコーポレイテッド 臓器の再建および増強のための骨格
US20070214097A1 (en) 2006-02-28 2007-09-13 Todd Parsons Social analytics system and method for analyzing conversations in social media
ES2432395T3 (es) 2006-10-12 2013-12-03 Ethicon, Inc. Células derivadas de riñon y metodo de uso en la reparación y regeneración tisular
US8048636B2 (en) * 2007-03-05 2011-11-01 Northshore University Healthsystem Methods of screening for modulators of h2-calponin activity
AU2008262333B2 (en) 2007-06-08 2014-07-17 Wake Forest University Health Sciences Selective cell therapy for the treatment of renal failure
RU2373942C2 (ru) * 2007-12-26 2009-11-27 Федеральное государственное учреждение "Научный Центр акушерства, гинекологии и перинатологии Федерального агентства по высокотехнологичной медицинской помощи" Способ лечения хронической и острой почечной недостаточности с помощью фетальных стволовых и прогениторных клеток
US20110053157A1 (en) 2008-02-01 2011-03-03 The General Hospital Corporation Use of microvesicles in diagnosis, prognosis and treatment of medical diseases and conditions
EP2186883A1 (en) * 2008-11-04 2010-05-19 Fresenius Medical Care An isolated multipotent mesenchymal stem cell from human adult glomeruli (hGL-MSC), a method of preparing thereof and uses thereof in the regenerative medicine of the kidney
KR20170041279A (ko) 2008-11-04 2017-04-14 리젠메드 (케이만) 엘티디. 세포-지지체 구조물
CN102271692B (zh) 2008-11-12 2014-05-21 坦吉恩股份有限公司 分离的肾细胞及其用途
WO2011017678A1 (en) * 2009-08-07 2011-02-10 Rules-Based Medicine, Inc. Methods and devices for detecting obstructive uropathy and associated disorders
CA2780320A1 (en) * 2009-11-12 2011-05-19 Tengion, Inc. Rational design of regenerative medicine products
WO2011096894A2 (en) 2010-02-04 2011-08-11 Agency For Science Technology And Research Use of novel markers of pluripotent stem cells
US20150030657A1 (en) 2010-05-03 2015-01-29 Tengion, Inc. Smooth muscle cell constructs
EP2569418B1 (en) * 2010-05-12 2016-11-02 RegenMed (Cayman) Ltd. Bioactive renal cells
WO2011156642A1 (en) 2010-06-11 2011-12-15 Tengion, Inc. Erythropoietin-expressing adipose cell populations
KR101913874B1 (ko) 2010-11-10 2018-10-31 인리젠 장기 확대를 위한 주사가능 제제
EP2760995B1 (en) * 2011-09-30 2019-08-07 The University Of Miami Renal stem cells isolated from kidney
EP3425391A1 (en) 2011-11-04 2019-01-09 inRegen Drug screening and potency assays
WO2014066699A1 (en) 2012-10-24 2014-05-01 Tengion, Inc. Renal cell populations and uses thereof
WO2014066698A1 (en) 2012-10-24 2014-05-01 Metavana, Inc. Method and system for social media burst classifications
BR112015027996A8 (pt) * 2013-05-08 2017-09-26 Regenmedtx Llc Organoides compreendendo células renais isoladas e suas utilizações
US11123372B2 (en) 2016-07-29 2021-09-21 Prokidney Bioactive renal cells for the treatment of chronic kidney disease
CN111182921A (zh) * 2017-06-21 2020-05-19 蒂莫西.A.伯特伦 用于治疗肾疾病的免疫豁免的生物活性肾细胞
AU2021377272A1 (en) * 2020-11-13 2023-06-22 Timothy A. Bertram Enriched bioactive renal cell populations, characteristics and uses thereof

Also Published As

Publication number Publication date
AU2019204178A1 (en) 2019-07-04
RU2019118791A (ru) 2019-07-11
AU2019204178B2 (en) 2021-11-18
SI2912165T1 (sl) 2019-11-29
DK2912165T3 (da) 2019-09-16
US10363274B2 (en) 2019-07-30
KR102215476B1 (ko) 2021-02-17
NZ741724A (en) 2020-02-28
CN104937095A (zh) 2015-09-23
US20150246073A1 (en) 2015-09-03
EP3567099B1 (en) 2021-04-21
EP2912165A1 (en) 2015-09-02
KR20200113287A (ko) 2020-10-06
BR112015009042B1 (pt) 2021-10-19
EP3901251A1 (en) 2021-10-27
WO2014066699A1 (en) 2014-05-01
CN104937095B (zh) 2019-06-07
KR102160725B1 (ko) 2020-09-29
EP2912165B1 (en) 2019-06-19
JP2019141067A (ja) 2019-08-29
EP3567099A1 (en) 2019-11-13
CN110184232B (zh) 2023-10-20
CA2889270A1 (en) 2014-05-01
PL2912165T3 (pl) 2020-01-31
HK1215448A1 (zh) 2016-08-26
AU2013334276B2 (en) 2019-07-04
US20220347221A1 (en) 2022-11-03
NZ707873A (en) 2019-01-25
BR112015009042A8 (pt) 2017-10-10
BR122020018576B1 (pt) 2022-07-05
HUE046176T2 (hu) 2020-02-28
DK3567099T3 (da) 2021-06-07
AU2013334276A1 (en) 2015-05-14
KR20220150419A (ko) 2022-11-10
RU2015119514A (ru) 2016-12-20
ES2744979T3 (es) 2020-02-27
PL3567099T3 (pl) 2021-11-29
ES2876177T3 (es) 2021-11-12
US11369639B2 (en) 2022-06-28
AU2022201010A1 (en) 2022-03-03
RU2702721C2 (ru) 2019-10-09
BR112015009042A2 (pt) 2017-07-04
US20170281684A1 (en) 2017-10-05
JP2016504017A (ja) 2016-02-12
KR102460536B1 (ko) 2022-10-31
CN110184232A (zh) 2019-08-30
CN117660296A (zh) 2024-03-08
JP6509119B2 (ja) 2019-05-08
US20200101112A1 (en) 2020-04-02
KR20210018965A (ko) 2021-02-18
PT2912165T (pt) 2019-09-26
JP6696023B2 (ja) 2020-05-20
HUE054882T2 (hu) 2021-10-28
KR20150085818A (ko) 2015-07-24

Similar Documents

Publication Publication Date Title
ES2744979T8 (es) Poblaciones de células renales y usos de las mismas
DK2900806T3 (da) Tredimensionel celledyrkning
CO7091186A2 (es) N-ciclilamidas como nematicidas
BR112015008209A2 (pt) métodos e sistemas de concentrador de oxigênio
CO7030961A2 (es) Benzotienilo-pirrolotriazinas disustituidas y sus usos
BR112015006198A2 (pt) conjunto de cadeira
DK2817406T3 (da) Engangsseparator til tilbageholdelse og tilbageføring af celler
BR112014029365A2 (pt) inibidores seletivos de células indiferenciadas
DE112012006872T8 (de) Numeriksteuervorrichtung
BR112014016917A2 (pt) processamento de células
FR2995524B1 (fr) Prothese endo-urinaire
DK3421997T3 (da) Cellemedieret immunresponsanalyse
SMT201700011B (it) Stent
ES1077924Y (es) Marquesina seguidor solar
BR302012006072S1 (pt) Configuracao em conjunto de talheres
BR302012006074S1 (pt) Configuracao em conjunto de talheres
BR112014025756A2 (pt) Procedimento de ativação de célula pequena
BR302012003015S1 (pt) Configuração em organizador de talheres
FI9821U1 (fi) Veitsiteline
BR302012003637S1 (pt) Configuração ornamental em cepo
ES1076526Y (es) Seguidor solar multiposte
BR302012003544S1 (pt) Configuracao aplicada em solado
BR302012003303S1 (pt) Configuração aplicada em solado
BR302012003174S1 (pt) Configuração aplicada em solado
BR302012003166S1 (pt) Configuração aplicada em solado